EnnoDC presents positive Phase I data at CROI 2025, demonstrating long-lasting immunity induced by Antibody Mediated Vaccines (AMVs) Findings in HIV highlight AMV technology's versatility, robust ...
The collaboration combines Salipro Biotech’s unique expertise and its Salipro® platform technology to stabilise challenging drug targets from Boehringer Ingelheim’s drug discovery programs to enable ...
To enable this innovation, Medigene combined TCR-guided precision targeting with innate NK cell killing. The Company has developed a proprietary universal scaffold that allows its 3S TCRs to function ...
LTC ACO is the first Accountable Care Organization (ACO) in the United States dedicated to long-term care facility residents. LTC ACO began participating in the Medicare Shared Savings Program (MSSP) ...
LAS VEGAS, March 13, 2025 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives Inc. (OTC: BDPT) today announced the successful completion of dosage trials for its innovative weight loss product, Zeranovia™.
Pills2Me, the rapidly growing on-demand prescription delivery service, today announced its nationwide rollout, set to begin in Q2 of 2025. This ambitious expansion follows a major milestone of ...
The Company intends on filing its 10K by the end of March and plans to provide a more in-depth Corporate Update at that time. About Aclarion, Inc.
Seventh Generation of Industry-Leading Exoskeleton Includes New and Enhanced Features for Individuals with Spinal Cord Injury ...
Communiqué de mise à disposition des comptes consolidés au 31 décembre 2024. Le Groupe annonce avoir mis à la disposition du public ses comptes consolidés au 31 décembre 2024 sur le site internet du G ...
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 28 février 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback